"I don't see this bio-defense sector going anywhere but up, " says Thomas Monath , chief scientific officer for Acambis (nasdaq: ACAM - news - people ).
FORBES: Biotechs See Dollar Signs In War
应用推荐
模块上移
模块下移
不移动